Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

I read your recent column where you said that ivermectin has not been proven to be an effective treatment for cancer. I feel ...

A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart procedure.

Stereotaxis is pushing the positives of its robotic magnetic navigation systems, MAGiC cardiac catheters and EMAGIN ...

The mom was 20 weeks pregnant when she discovered that her twins, Graylen and Chaysen, had twin-to-twin transfusion syndrome.

Abbott Laboratories ( NYSE: ABT) Q3 2025 Earnings Call October 15, 2025 9:00 AM EDT ...

These Dividend Aristocrat stocks offer the great value and entry points for investors seeking dependable income with growth ...

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...

Here are the surgeons leading the cardiology departments for U.S. News & World Report‘s top five hospitals for cardiology and heart and vascular surgery in 2025-26. 1. NYU Langone Health (New York ...

Pulse Biosciences PLSE recently reported encouraging late-breaking data from the first-in-human feasibility study of its ...

The DVLA has issued a full list of health conditions that drivers must report to them or risk facing a £1,000 fine ...